Development of a circadian-related prognostic signature highlights RBM17 as a stemness regulator in liver cancer. - Yan, Jingsong; Yang, Xiao; Lu, Jiabin; Wu, Shasha; Wang, Yanchen; Du, Yuyang; Zheng, Jingyi; Wang, Fenfen; Gao, Han; Yang, Hui; Xi, Shaoyan; Li, Yan (Cancer Cell International, 2025)